Zyga gets 510(k) clearance; Study finds information sharing needed when it comes to organ transplants;

@FierceMedDev: Roche shells out up to $425M for superbug testing outfit. FierceDiagnostics news | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Google joins forces with Dexcom for miniaturized glucose monitor. Article | Follow @VarunSaxena2

@EmilyWFierce: NICE plots takeover of England's Cancer Drugs Fund. FiercePharma article | Follow @EmilyWFierce

> Zyga Technologies received a 510(k) clearance from the FDA for its SImmetry System to treat lumbar spine conditions. More

> A study found that there is a need to increase the sharing of information between organ donors and their recipients. More

Biotech News

@FierceBiotech: FierceBiotech Radio on Amarin's First Amendment crusade, Martin Shkreli's Twitter, and Kim Kardashian's Instagram. Listen/Subscribe | Follow @FierceBiotech

@JohnCFierce: California cutbacks: Boston Sci to close two facilities, Abbott cuts 160+ employees. FierceMedicalDevices article | Follow @JohnCFierce

@DamianFierce: ICYMI: A wonderfully stern FDA official parses Kim Kardashian's Instagram. Letter | Follow @DamianFierce

> KemPharm spikes as its anti-abuse pain drug rolls toward the FDA. Story

> Lilly's CEO keeps faith in the pipeline as biotech gets 'too expensive.' Article

> CRO giant WuXi is going private in a $3.3B deal. News

> Avalanche hits the brakes on its gene therapy program after a Phase II misstep. Report

Pharma News

@FiercePharma: China FDA issues software guidelines on medical devices effective this month. FiercePharmaAsia story | Follow @FiercePharma

@EricPFierce: Sun U.S. sales gut-kicked by supply constraints as it works on FDA concerns at Halol plant. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Biogen touts new Eloctate data as next-gen hemophilia rivals near the scene. FiercePharmaMarketing article | Follow @CarlyHFierce

> Novo says new U.S. plant may be best bet to offset the FX bite. More

> Shire raise its $30B Baxalta bid? It's going to need some details first. Article

> Takeda Actos settlement seems shaky as plaintiffs give it the sniff test. Story

> NICE plots takeover of England's Cancer Drugs Fund. Report

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.